Glassia FDA Approval
Links shared publicly online about this topic
Glassia approved for treating alpha 1 antitrypsin deficiency - ONA
oncologynurseadvisor.com — “Kamada announced that the FDA has approved Glassia (alpha1-proteinase inhibitor liquid) for chronic augmentation and maintenance therapy in adults with emphysema due to congenital deficiency of alpha1-proteinase inhibitor (AATD).” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 6, 2010 at 3:53 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Glassia approved for treating alpha 1 antitrypsin deficiency http://goo.gl/fb/xUQkp
Kamada Wins FDA Approval for Glassia - a New Liquid, Ready-to-Use Treatment for Alpha-1 Antitrypsin Deficiency
drugs.com — “Glassia (alpha1-proteinase inhibitor (human)) is used to treat Alpha 1 deficiency. Includes Glassia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 7, 2010 at 9:27 am By:
FDA Approves Glassia - a New Liquid, Ready-to-Use Treatment for Alpha-1 Antitrypsin Deficiency - http://bit.ly/bpOUdG
Glassia approved for treating alpha 1 antitrypsin deficiency - MPR
empr.com — “Kamada announced that the FDA has approved Glassia (alpha1-proteinase inhibitor liquid) for chronic augmentation and maintenance therapy in adults with emphysema due to congenital deficiency of alpha1-proteinase inhibitor (AATD).” View full resource at empr.com
Most Recently Shared on July 6, 2010 at 3:33 pm By:
MPR News: Glassia approved for treating alpha 1 antitrypsin deficiency: Kamada announced that the FDA has approved... http://bit.ly/bedZ9o
FDA Approves Trial For Type 1 Diabetes Treatment By Ben-Gurion U. And U. Colorado | Chem.Info
chem.info — “( American Associates, Ben-Gurion University of the Negev ) This is the first time AAT will be evaluated in humans with type 1 diabetes. AAT is an FDA-approved off-patent drug currently used to treat pulmonary emphysema. " We designed the trial with the same dose of AAT that has been used safely and effectively for over 20 years," explains Dr. Lewis, who is the director of Israel' s only Clinical Islet Laboratory and a senior lecturer in the Department of Clini” View full resource at chem.info
Most Recently Shared on June 29, 2010 at 10:08 pm By:
http://tinyurl.com/26qnd6x FDA Approves Trial For Type 1 Diabetes Treatment By Ben-Gurion U. And U. Colorado
FDA Approves Emergency Contraceptive:
health.msn.com — “FDA Approves Emergency Contraceptive:” View full resource at health.msn.com
Most Recently Shared on August 14, 2010 at 1:44 pm By:
FDA Approves Emergency Contraceptive: http://bit.ly/bOqq6o
Hernia Mesh Approved by FDA
hcplive.com — “he Biomerix Ventral Hernia Repair Mesh has received FDA approval to be marketed” View full resource at hcplive.com
Most Recently Shared on July 21, 2010 at 4:03 pm By:
Hernia Mesh Approved by FDA http://hcp.lv/9hMpow
FDA approves ablation catheters
theheart.org — “UPDATED // The Food and Drug Administration today approved the first ablation catheters for the treatment of atrial fibrillation.” View full resource at theheart.org
Most Recently Shared on February 6, 2009 at 11:35 pm By:
FDA approves AF ablation catheters http://tinyurl.com/c65a4f
FDA Approves Emergency Contraceptive
everydayhealth.com — “Called 'ella,' drug delays ovulation, but opponents say it's another abortion pill” View full resource at everydayhealth.com
Most Recently Shared on August 15, 2010 at 2:56 am By:
FDA approves a new emergency contraceptive http://ht.ly/2pIID #health #women #birthcontrol #ella
FDA approves tolvaptan
theheart.org — “The Food and Drug Administration has approved tolvaptan, a selective vasopressin-receptor antagonist that can be taken orally, for the treatment of patients with clinically significant hypervolemic and euvolemic hyponatremia,” View full resource at theheart.org
Most Recently Shared on May 27, 2009 at 9:59 pm By:
heartwire: FDA approves tolvaptan for hyponatremia http://bit.ly/1aO6Mx
FDA approves pitavastatin
theheart.org — “Available in Japan since 2003, the newest statin joins six others on the US market.” View full resource at theheart.org
Most Recently Shared on August 4, 2009 at 4:17 pm By:
heartwire: FDA approves pitavastatin, a new cholesterol-lowering drug http://bit.ly/129mcX
The High Price Of FDA Approval
medicalnewstoday.com — “The Food and Drug Administration is trying to get some unapproved drugs off the market, Kaiser Heal” View full resource at medicalnewstoday.com
Most Recently Shared on January 5, 2010 at 7:12 pm By:
The High Price Of FDA Approval - The Food and Drug Administration is trying to get some unapproved drugs off the ma... http://ow.ly/16gWJo
FDA gives Micardis wider approval
healthcentral.com — “FDA gives Micardis wider approval” View full resource at healthcentral.com
Most Recently Shared on October 21, 2009 at 3:46 pm By:
healthcentral: FDA gives Micardis wider approval http://bit.ly/1xUISY Full http://bit.ly/30K9QS
FDA Approves Prostate Cancer Vaccine
healthcentral.com — “Provenge may soon get FDA approval.” View full resource at healthcentral.com
Most Recently Shared on April 29, 2010 at 10:03 pm By:
HealthCentral Tips Health Site
#FDA Approves #Prostate #Cancer Vaccine: http://bit.ly/9nFXo8
FDA Approves Injectable Osteoporosis Drug
healthcentral.com — “FDA approves Prolia.” View full resource at healthcentral.com
Most Recently Shared on June 7, 2010 at 8:25 am By:
#osteoporosis FDA Approves Injectable Osteoporosis Drug http://w.sns.ly/K1k49
Butrans" Approved by FDA for Pain Management
hcplive.com — “Butrans™ (buprenorphine) Transdermal System CIII was approved by the FDA” View full resource at hcplive.com
Most Recently Shared on July 7, 2010 at 4:11 pm By:
Butransâ„¢ Approved by FDA for Pain Management http://hcp.lv/9akcMt
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
